TY  - GEN
AU  - Malard,Florent
AU  - Labopin,Myriam
AU  - Yakoub-Agha,Ibrahim
AU  - Chantepie,Sylvain
AU  - Guillaume,Thierry
AU  - Blaise,Didier
AU  - Tabrizi,Reza
AU  - Magro,Leonardo
AU  - Vanhove,Bernard
AU  - Blancho,Gilles
AU  - Moreau,Philippe
AU  - Gaugler,Béatrice
AU  - Chevallier,Patrice
AU  - Mohty,Mohamad
TI  - Rituximab-based first-line treatment of cGVHD after allogeneic SCT: results of a phase 2 study
SN  - 1528-0020
PY  - 2017///1128
KW  - Adrenal Cortex Hormones
KW  - therapeutic use
KW  - Adult
KW  - B-Lymphocytes
KW  - pathology
KW  - B7-H1 Antigen
KW  - Chronic Disease
KW  - Cyclosporine
KW  - Drug Combinations
KW  - Graft vs Host Disease
KW  - drug therapy
KW  - Humans
KW  - Lymphocyte Count
KW  - Middle Aged
KW  - Rituximab
KW  - administration & dosage
KW  - Stem Cell Transplantation
KW  - adverse effects
KW  - Survival Rate
KW  - T-Lymphocytes, Helper-Inducer
KW  - cytology
KW  - Transplantation, Homologous
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1182/blood-2017-05-786137
ER  -